Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Latexin deletion in the bone marrow niche suppresses leukemia via LIFR downregulation and immune activation
Cuiping Zhang, Xia Yao, Pinpin Sui, Liming Hou, Bowen Yan, Larry L. Luchsinger, Gang Huang, Sheng Tong, Youwen Zhang, Bojing Shao, Hong Qian, Hong Zheng, Hui Zhong, Feng-Chun Yang, Ying Liang
Cuiping Zhang, Xia Yao, Pinpin Sui, Liming Hou, Bowen Yan, Larry L. Luchsinger, Gang Huang, Sheng Tong, Youwen Zhang, Bojing Shao, Hong Qian, Hong Zheng, Hui Zhong, Feng-Chun Yang, Ying Liang
View: Text | PDF
Research Article Hematology Oncology

Latexin deletion in the bone marrow niche suppresses leukemia via LIFR downregulation and immune activation

  • Text
  • PDF
Abstract

Acute myeloid leukemia (AML) is the most common adult leukemia diagnosis. Bone marrow (BM) niche significantly influences the initiation and progression of AML. However, our knowledge about the effect of leukemic niche on leukemia stem cells (LSC) and leukemogenesis is limited. In this study, we identified an extrinsic-regulatory function of latexin (Lxn) in leukemogenesis. Using a MLL-AF9–induced AML mouse model in WT and Lxn-KO (Lxn–/–) recipient mice, we found that Lxn deletion in the BM niche enhanced the survival of AML mice by suppressing LSCs and reducing blood blasts. Single-cell RNA-seq of stromal cells and cell communication analysis uncovered downregulation of the leukemia inhibitory factor receptor (LIFR) signaling pathway in the Lxn–/– niche, particularly within mesenchymal stromal cells (MSCs). Mechanistically, reduced LIFR level in Lxn–/– MSCs upregulated Cxcl9 expression, leading to increased recruitment of CD8 T cells and enhanced cytotoxicity against leukemic cells. Combination of Lxn niche deletion and immune checkpoint inhibitor PD-1 further prolonged survival. The findings have important clinical implications, suggesting that Lxn inhibition could improve the efficacy of AML therapies by targeting the leukemia niche and enhancing immune surveillance.

Authors

Cuiping Zhang, Xia Yao, Pinpin Sui, Liming Hou, Bowen Yan, Larry L. Luchsinger, Gang Huang, Sheng Tong, Youwen Zhang, Bojing Shao, Hong Qian, Hong Zheng, Hui Zhong, Feng-Chun Yang, Ying Liang

×

Figure 6

Lxn–/– MSCs enhance CD8+ T cell–mediated cytotoxicity against AML cells through CXCL9.

Options: View larger image (or click on image) Download as PowerPoint
Lxn–/– MSCs enhance CD8+ T cell–mediated cytotoxicity against AML cells ...
(A) Schematic representation of the transwell coculture system in which MSCs and MA9-AML cells were placed in the lower chamber, and CD8+ T cells were placed in the upper chamber. (B) Quantification of CD8+ T cells migrating into the lower chamber after coculture with WT or Lxn–/– MSCs, demonstrating enhanced T cell recruitment by Lxn–/– MSCs. (C) Relative MA9 AML cell number after coculture, showing reduced AML cell survival cultured with the Lxn–/– MSCs. (D) Relative dead cells in CD8 T cells cocultured with WT or Lxn–/– MSCs and MA9 cells, showing increased cell death in the Lxn–/– MSCs. (E and F) Neutralization of CXCL9 or inhibition of CXCR3 signaling via AMG-487 (1 μM) in the transwell system abolished the enhanced CD8+ T cell recruitment (E) and AML cell killing (F) induced by Lxn–/– MSCs. In B, C, E, and F, the number of migrated CD8+ T cells is presented as relative fold change normalized to the CD8 T and MA9-AML cells coculture group, which was set to 1. (G–I) Lifr was overexpressed in Lxn–/– MSCs, and then cocultured with MA9-AML cells and CD8+ T cells. Lifr overexpression increased STAT3 phosphorylation (G), reduced CD8+ T cell migration (H), and increased AML cell survival (I). Data are shown as mean ± SD for the indicated number of samples from a single experiment. Comparisons among 3 or more groups were performed using 1-way ANOVA followed by Tukey’s multiple-comparisons test. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts